Skip to content

Data Migration and Mapping Functions

Data Migration and Mapping Functions

Medical software does not have a good reputation for user experience and intuitive design. It can seem like a full-time job just learning how to use these software solutions.  In fact, according to a study from Stanford Medicine, 74% of doctors responded that their EMR increased the number of hours they work every day and 71% say their EMRs lead to physician burnout.  With this information, coupled with the increase use of telehealth (another software to learn), it’s no wonder that providers and their staff are looking for alternatives to simplify their clinical software, while not sacrificing the quality of patient care.

At Arfinn Med, we believe that your clinical software should be easy to use, fast and allow you to spend more time focusing on patient care rather than data entry. This focus on intuitive software design is why we are the leading EMR for alternative medicine clinics including practices focusing on cannabis and cannabinoid medicine.  Despite this, we still hear from providers who wish to switch to our platform that they are concerned about migrating data from paper charts or from another system.  We at Arfinn Med decided to address this concern.

We are proud to release our new secure data mapping software and a team of employees to focus on data migration.  This new system will allow us to speed up the time it takes to switch patient data, while also not interrupting your current practice workflows. You will also be assigned a team member from Arfinn to help with extraction of any additional data such as attached files, appointments and/or consents.

If you are interested in learning more about our data migration protocol, please reach out to us at info@arfinnmed.com.

Sincerely from quarantine,

The Arfinn Med Team

Stories you may be interested in

Systematic review: Efficacy and safety of medical marijuana in selected neurologic disorders

Report of the Guideline Development Subcommittee of the American Academy of Neurology:   We performed a systematic review of medical marijuana (1948–November 2013) to address treatment of symptoms of multiple sclerosis (MS), epilepsy, and movement disorders. We graded the studies according to the American Academy of Neurology classification scheme for therapeutic articles. Read the full…
Read More

Alternative Mississippi medical marijuana program barely wins approval from Senate

JACKSON • Legislation that would create a new medical marijuana program in Mississippi if the voter-approved Initiative 65 is overturned in court cleared the state Senate on the second try last week early on Friday morning. Senate Bill 2765, the Mississippi Medical Cannabis Act, failed by a single vote Thursday evening. But six hours later, after…
Read More

After A Decade Of Testing, Israeli Medical Cannabis Comes To The US

Cannabis is still federally illegal, so while more than 30 US states allow doctors to recommend it, there is very little medical testing of the substance in America. In Israel however, medical cannabis has been legal for more than ten years and studies on the plant’s ability to alleviate the side-effects of cancer and ease…
Read More

A Message To Our Clients

To Our Clients, First of all, I hope everyone is staying safe and healthy in these unprecedented times.  I want to assure you that Arfinn Med has systems in place to ensure that our workflows are not impacted from having staff work remotely and we will continue to provide the same quality product and customer service…
Read More

July Updates

In our quest to save medical marijuana clinics valuable time, Arfinn Med has continued to release new functionality that improves EMR workflows.  This has led to the development of our new telehealth platform, new automated patient intake emails, and generating all state required documentation.  Continuing on our quest, we are proud to release our new…
Read More

Norfolk research company plans clinical trials using medical marijuana

Eighteen months after receiving a broad federal license for importing medical cannabis, a Norfolk research company is about to embark on a series of critical studies into a variety of medical and mental disorders, diseases and conditions. Sanyal Biotechnology is already considering proposals for research campuses and planning its first clinical trial for this summer.…
Read More

Leave a Comment

You must be logged in to post a comment.